Conditions · Pancreatic cancer
Pancreatic cancer — Phase 3 trials
Prefer to look first? Browse the live map without signing up.
5 open options
- TRIALPHASE3RECRUITING
Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer
Irinotecan Hydrochloride Liposome Injection (II); Oxaliplatin; 5Fluorouracil; Calcium folinate · nab-paclitaxel; gemcitabine — 1 site
- TRIALPHASE3RECRUITING
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
Immuncell-LC · Gemcitabine — 1 site
- TRIALPHASE3RECRUITING
Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound
Auricular point stimulation plus dexamethasone · Standard pharmacologic antiemetic regimen — 1 site
- TRIALPHASE3RECRUITING
Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
XNW28012 for injection · XNW28012 Mimetic for Injection — 48 sites
- TRIALPHASE3RECRUITING
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
HRS-4642 + AG · HRS-4642 placebo + AG — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.